Thomas Dohlman

Thomas Dohlman is an Assistant Professor of Ophthalmology at Harvard Medical School, affiliated with the Department of Ophthalmology at Boston Children's Hospital. He earned his MD from the University of Massachusetts Medical School and holds a BS from MIT.

• Education
  • BS, Massachusetts Institute of Technology
  • MD, University of Massachusetts Medical School

Dr. Dohlman is a clinician-scientist specializing in corneal and external eye diseases, with active research in corneal immunology, transplantation, and ocular surface disorders. His work bridges basic science and clinical applications, focusing on immune modulation in graft survival and fibrosis prevention.

Recent publications highlight his expertise in uveitis treatment, limbal stem cell transplantation, and neurotrophic keratopathy. He employs murine models to study transplantation immunology and develops novel therapies like alpha-Melanocyte Stimulating Hormone for corneal protection.

Dr. Dohlman's clinical practice includes managing pediatric corneal diseases, dry eye, and ocular trauma. He is part of Boston Children's Hospital's multidisciplinary ophthalmology team with national leadership in pediatric cataract surgery and retinal disease management.

Key Research Trends

• Immune regulation in corneal grafts
• Neuropeptide-based ocular therapies
• Stem cell applications for ocular surface repair
• Epidemiology of corneal opacity
• Anti-vascular endothelial growth factor treatments